AbbVie inks AI drug discovery collaboration deal with Iambic across three therapeutic areas
AllThingsApx · x · 2026-09-22
Pharma giant AbbVie announced a collaboration with AI drug discovery company Iambic to advance AI-enabled drug discovery across immunology, neuroscience and oncology — another notable big-pharma × AI-biotech deal.
More from Venture
- Strategy 101: incumbents tie complements, entrants break them — enter Muse — Afinetheorem · 2026-09-22
- Why Shopify says yes to Muse and Amazon says no: complements economics — Afinetheorem · 2026-09-22
- Deel launches Akai: 8,000 agents doing work of ~600 employees, added $140M ARR in 90 days — AIwithGhotai · 2026-09-22
- YouTube Premium's weak uptake is the strongest proof consumer AI agents can't be subscription-based — ivan_bezdomny · 2026-09-22
- APIHub Launches Pay-Per-Call API Marketplace for AI Agents With USDC — modelcontextprotocol · 2026-09-22
- SB Energy's $50B-Valuation IPO for World's Largest Data Center Project Delayed on Weak Investor Demand — firstadopter · 2026-09-22